Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01164784
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
31U![]() | D-leucyl-N-(4-carbamimidoylbenzyl)- L-prolinamide | H,I | 2ZNK | 0.72 | ![]() |
53U![]() | D-phenylalanyl-N-benzyl-L-prolinamide | H,I | 2ZFF | 0.72 | ![]() |
49U![]() | (S)-N-(4-carbamimidoylbenzyl)-1- (3-cyclopentylpropanoyl)pyrrolidine- 2-carboxamide | A | 2ZDN | 0.73 | ![]() |
49U![]() | (S)-N-(4-carbamimidoylbenzyl)-1- (3-cyclopentylpropanoyl)pyrrolidine- 2-carboxamide | H,I | 2ZHF | 0.73 | ![]() |
IN9![]() | 2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL- 2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL- PROPIONAMIDE | A | 1USN | 0.74 | ![]() |
IZD![]() | ISOTHIAZOLIDINONE ANALOG | A | 2CM7 | 0.7 | ![]() |
T29![]() | TRI166 (BIFUNCTIONAL BORONATE INHIBITOR) | H | 1A3B | 0.73 | ![]() |
DP7![]() | AC-(D)PHE-PRO-BOROARG-OH | H | 1LHC | 0.73 | ![]() |
10U![]() | (S)-N-(4-carbamimidoylbenzyl)-1- (2-(cyclopentylamino)ethanoyl)pyrrolidine- 2-carboxamide | A | 2ZFT | 0.71 | ![]() |
10U![]() | (S)-N-(4-carbamimidoylbenzyl)-1- (2-(cyclopentylamino)ethanoyl)pyrrolidine- 2-carboxamide | H,I | 3BIU | 0.71 | ![]() |
27U![]() | N-(4-carbamimidoylbenzyl)-1-(3- phenylpropanoyl)-L-prolinamide | H,I | 2ZHQ | 0.76 | ![]() |
G23![]() | (2R,4S)-2-[(R)-BENZYLCARBAMOYL- PHENYLACETYL-METHYL]-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | A | 1HTE | 0.71 | ![]() |
IN8![]() | [2-(5-MERCAPTO-[1,3,4]THIADIAZOL- 2-YLCARBAMOYL)-1-PHENYL-ETHYL]- CARBAMIC ACID BENZYL ESTER | A | 2USN | 0.72 | ![]() |
37U![]() | D-phenylalanyl-N-(3-fluorobenzyl)- L-prolinamide | H,I | 2ZDV | 0.71 | ![]() |
MIN![]() | METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE | H,I | 1TOM | 0.7 | ![]() |
33U![]() | beta-phenyl-D-phenylalanyl-N-(4- carbamimidoylbenzyl)-L-prolinamide | H,I | 2ZO3 | 0.73 | ![]() |
11U![]() | (S)-N-(4-carbamimidoylbenzyl)-1- (2-(cyclohexylamino)ethanoyl)pyrrolidine- 2-carboxamide | H,I | 3BIV | 0.74 | ![]() |
26U![]() | N-(4-carbamimidoylbenzyl)-1-(4- methylpentanoyl)-L-prolinamide | H,I | 2ZIQ | 0.72 | ![]() |
BI6![]() | (3S,6S,7Z,10AS)-N-(DIPHENYLMETHYL)- 6-{[(2S)-2-(METHYLIDENEAMINO)BUTANOYL]AMINO}- 5-OXO-1,2,3,5,6,9,10,10A-OCTAHYDROPYRROLO[1,2- A]AZOCINE-3-CARBOXAMIDE | A | 2JK7 | 0.7 | ![]() |
D7P![]() | D-PHENYLALANYL-N~5~-[(2,2-DIHYDROXYHYDRAZINO)(IMINO)METHYL]- D-ORNITHINAMIDE | A,B | 1RS7 | 0.71 | ![]() |
D7P![]() | D-PHENYLALANYL-N~5~-[(2,2-DIHYDROXYHYDRAZINO)(IMINO)METHYL]- D-ORNITHINAMIDE | A,B | 1RS9 | 0.71 | ![]() |
29U![]() | 1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)- L-prolinamide | H,I | 2ZGX | 0.73 | ![]() |
32U![]() | D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}- L-prolinamide | H,I | 2ZDA | 0.76 | ![]() |
12U![]() | N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)- L-prolinamide | A | 2ZHD | 0.71 | ![]() |
12U![]() | N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)- L-prolinamide | H,I | 2ZHW | 0.71 | ![]() |
12U![]() | N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)- L-prolinamide | A | 2ZFS | 0.71 | ![]() |
FA4![]() | SM-25453 | A,B | 2D1O | 0.7 | ![]() |
FA4![]() | SM-25453 | A,B | 2D1N | 0.7 | ![]() |
13U![]() | N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)- L-prolinamide | H,I | 2ZHE | 0.71 | ![]() |
ATT![]() | 2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL- 2-YL)-UREIDO]-N-METHYL-3-PHENYL- PROPIONAMIDE | A | 3USN | 0.81 | ![]() |
51U![]() | D-phenylalanyl-N-(3-methylbenzyl)- L-prolinamide | H,I | 2ZF0 | 0.72 | ![]() |
50U![]() | (S)-N-(4-carbamimidoylbenzyl)-1- (3-cyclohexylpropanoyl)pyrrolidine- 2-carboxamide | A | 2ZDK | 0.75 | ![]() |
50U![]() | (S)-N-(4-carbamimidoylbenzyl)-1- (3-cyclohexylpropanoyl)pyrrolidine- 2-carboxamide | H,I | 2ZG0 | 0.75 | ![]() |
24U![]() | 1-butanoyl-N-(4-carbamimidoylbenzyl)- L-prolinamide | H,I | 2ZI2 | 0.73 | ![]() |
DI3![]() | AC-(D)PHE-PRO-BORO-N-BUTYL-AMIDINO- GLYCINE-OH | H | 1LHE | 0.71 | ![]() |